Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0454 EUR | +0.89% | -3.81% | +47.40% |
06-17 | Percheron Therapeutics Appoints CFO | MT |
06-03 | Percheron Therapeutics Names Chief Medical Advisor | MT |
Chart calendar Percheron Therapeutics Limited
Upcoming events on Percheron Therapeutics Limited
Past events on Percheron Therapeutics Limited
02/06/2024 | Bio International Convention |
29/04/2024 23:53 | March 2024 Sales and Revenue Release - Activities Report |
02/03/2024 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V410 |
02/03/2024 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V409 |
02/03/2024 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - M149 |
28/02/2024 06:20 | Q2 2024 Earnings Release |
30/01/2024 22:12 | December 2023 Sales and Revenue Release - Activities Report |
07/01/2024 | JPMorgan Healthcare Conference |
07/01/2024 | Biotech Showcase |
15/11/2023 03:00 | Annual General Meeting |
31/10/2023 | AusBiotech Conference |
30/10/2023 22:38 | September 2023 Sales and Revenue Release - Activities Report |
17/10/2023 21:45 | BIO Investor Forum |
08/09/2023 05:00 | ShareCafe Small Cap Hidden Gems Conference |
25/08/2023 09:08 | Q4 2023 Earnings Release |
28/07/2023 00:37 | June 2023 Sales and Revenue Release - Activities Report |
17/04/2023 00:38 | March 2023 Sales and Revenue Release - Activities Report |
22/02/2023 05:24 | Interim 2023 Earnings Release |
24/01/2023 | December 2022 Sales and Revenue Release - Activities Report |
17/11/2022 03:00 | Annual General Meeting |
Annual results
Fiscal Period | Juni | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 0,77 | 0,64 6,30 -89.89% | 1,81 1,40 29.41% | 1,96 1,80 9.15% | 3,60 |
EBITDA Million AUD | Released Forecast Spread | 0,00 | -7,95 -8,88 10.49% | -5,71 -11,3 49.31% | -11,3 -12,1 7.07% | -13,2 |
EBIT Million AUD | Released Forecast Spread | 0,00 | -8,05 -8,87 9.28% | -5,80 -11,3 48.6% | -11,4 -12,2 6.66% | -13,3 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 0,00 | -8,06 -8,20 1.7% | 0,00 0,00 - | -11,4 -8,80 -29.32% | -17,2 |
Net income Million AUD | Released Forecast Spread | 0,00 | -8,06 -8,96 10.02% | 0,00 0,00 - | -11,4 -11,9 4.72% | -13,1 |
EPS AUD | Released Forecast Spread | 0,00 | -0,01 -0,02 6.88% | 0,00 0,00 - | -0,02 -0,02 4.39% | -0,02 |
Announcement Date | 26/08/20 | 25/08/21 | 31/08/22 | 25/08/23 | - |
Quarterly results
Fiscal Period | Juni | 2021 S2 | 2024 S1 |
---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 1,20 0,00 - | |
EBITDA Million AUD | Released Forecast Spread | -6,01 -6,00 -0.17% | -4,69 -8,50 44.78% |
EBIT Million AUD | Released Forecast Spread | -6,01 -6,00 -0.17% | -4,74 -8,50 44.23% |
Net income Million AUD | Released Forecast Spread | -4,74 -8,60 44.85% | |
EPS AUD | Released Forecast Spread | -0,01 -0,01 40% | |
Announcement Date | 25/08/21 | 28/02/24 |
Past sector events for Percheron Therapeutics Limited
05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PER Stock
- AWY0 Stock
- Calendar Percheron Therapeutics Limited